Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma

被引:76
作者
Pandha, Hardev S. [1 ]
Heinemann, Lucy [1 ]
Simpson, Guy R. [1 ]
Melcher, Alan [2 ]
Prestwich, Robin [2 ]
Errington, Fiona [2 ]
Coffey, Matt [3 ]
Harrington, Kevin J. [4 ]
Morgan, Richard [1 ]
机构
[1] Univ Surrey, Postgrad Med Sch, Guildford GU2 7WG, Surrey, England
[2] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds, W Yorkshire, England
[3] Oncolyt Biotech Inc, Calgary, AB, Canada
[4] Inst Canc Res, Chester Beatty Labs, Targeted Therapy Team, London SW3 6JB, England
关键词
HERPES-SIMPLEX-VIRUS; PHASE-I; REPLICATING ADENOVIRUS; LIVER METASTASES; GENE-THERAPY; CANCER; COMBINATION; EFFICACY; GEMCITABINE; INFECTION;
D O I
10.1158/1078-0432.CCR-09-0796
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To test combination treatment schedules of reovirus and cisplatin chemotherapy in human and murine melanoma cell lines and murine models of melanoma and to investigate the possible mechanisms of synergistic antitumor effects. Experimental Design: The effects of reovirus +/- chemotherapy on in vitro cytotoxicity and viral replication were assessed using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay and plaque assay. Interactions between agents were assessed by combination index analysis. Mode of cell death was assessed by Annexin V/propidium iodide fluorescence-activated cell sorting-based assays; gene expression profiling of single versus combination treatments was completed using the Agilent microarray system. Single agent and combination therapy effects were tested in vivo in two immunocompetent models of murine melanoma. Results: Variable degrees of synergistic cytotoxicity between live reovirus and several chemotherapy agents were observed in B16.F10 mouse melanoma cells, most significantly with cisplatin (combination index of 0.42 +/- 0.03 at ED(50)). Combination of cisplatin and reovirus exposure led to increased late apoptotic/necrotic cell populations. Cisplatin almost completely abrogated the inflammatory cytokine gene up-regulation induced by reovirus. Combination therapy led to significantly delayed tumor growth and improved survival in vivo (P < 0.0001 and P = 0.0003, respectively). Cisplatin had no effect on the humoral response to reovirus in mice. However, cisplatin treatment suppressed the cytokine and chemokine response to reovirus in vitro and in vivo. Conclusion: The combination of reovirus and several chemotherapeutic agents synergistically enhanced cytotoxicity in human and murine melanoma cell lines in vitro and murine tumors in vivo. The data support the current reovirus/chemotherapy combination phase I clinical studies currently ongoing in the clinic. (Clin Cancer Res 2009; 15(19):6158-66)
引用
收藏
页码:6158 / 6166
页数:9
相关论文
共 37 条
[1]   Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma [J].
Adusumilli, PS ;
Chan, MK ;
Chun, YS ;
Hezel, M ;
Chou, TC ;
Rusch, VW ;
Fong, YM .
CANCER BIOLOGY & THERAPY, 2006, 5 (01) :48-53
[2]   Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV [J].
Angelova, Assia L. ;
Aprahamian, Marc ;
Grekova, Svitlana P. ;
Hajri, Amor ;
Leuchs, Barbara ;
Giese, Nathalia A. ;
Dinsart, Christiane ;
Herrmann, Alexia ;
Balboni, Ginette ;
Rommelaere, Jean ;
Raykov, Zahari .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :511-519
[3]  
Chahlavi Ali, 1999, Neoplasia (New York), V1, P162, DOI 10.1038/sj.neo.7900016
[4]  
Charalambous Marika, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P3, DOI 10.1097/MED.0b013e328013daa2
[5]   E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models [J].
Cheong, S. C. ;
Wang, Y. ;
Meng, J-H ;
Hill, R. ;
Sweeney, K. ;
Kirn, D. ;
Lemoine, N. R. ;
Hallden, G. .
CANCER GENE THERAPY, 2008, 15 (01) :40-50
[6]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[7]   Reovirus therapy of tumors with activated Ras pathway [J].
Coffey, MC ;
Strong, JE ;
Forsyth, PA ;
Lee, PWK .
SCIENCE, 1998, 282 (5392) :1332-1334
[8]   Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis [J].
DeBiasi, RL ;
Clarke, P ;
Meintzer, S ;
Jotte, R ;
Kleinschmidt-Demasters, BK ;
Johnson, GL ;
Tyler, KL .
JOURNAL OF VIROLOGY, 2003, 77 (16) :8934-8947
[9]   DIFFERENTIAL SENSITIVITY OF NORMAL AND TRANSFORMED HUMAN CELLS TO REOVIRUS INFECTION [J].
DUNCAN, MR ;
STANISH, SM ;
COX, DC .
JOURNAL OF VIROLOGY, 1978, 28 (02) :444-449
[10]   5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer [J].
Eisenberg, DP ;
Adusumilli, PS ;
Hendershott, KJ ;
Yu, ZK ;
Mullerad, M ;
Chan, MK ;
Chou, TC ;
Fong, Y .
JOURNAL OF GASTROINTESTINAL SURGERY, 2005, 9 (08) :1068-1077